Ixoreal Biomed has been offering its KSM-66 Ashwagandha for about five years, after spending nearly 14 years perfecting the production process and investing in scientific research to substantiate the health benefits. The companys singular focus on ashwagandha has allowed it to incrementally scale globally, working actively to develop relationships from the farm through the supply chain, and with academic institutions and governments.
- Substantiation of all health benefits with trials performed using the actual ingredient support market positioning.
- Supply chain control and full traceability is critical to meeting international regulatory requirements.
- Certifications like ISO, GMP and organic provide assurance that a company is committed to best practices.
